BioRem Inc. (BRM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BioRem Inc. (BRM) has a cash flow conversion efficiency ratio of -0.074x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-1.13 Million ≈ $-816.89K USD) by net assets (CA$15.30 Million ≈ $11.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BioRem Inc. (BRM) liquidity interval to measure how many days the company can operate on defensive assets alone.
BioRem Inc. - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how BioRem Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
BioRem Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioRem Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dimension Computer Technology Co Ltd
TWO:6140
|
0.186x |
|
STRUCT.MONIT.SYSCDIS
F:RJP
|
N/A |
|
WESTBRIDGE RE. EN. CORP.
F:PUQ
|
N/A |
|
Adcorp
JSE:ADR
|
-0.111x |
|
Eternal Energy Public Company Limited
BK:EE
|
-0.078x |
|
TAEYANG Corporation
KQ:053620
|
0.035x |
|
Ostim Endustriyel Yatirimlar ve Isletme AS
IS:OSTIM
|
-0.011x |
|
Relief Therapeutics Holding AG
SW:RLF
|
-0.115x |
Annual Cash Flow Conversion Efficiency for BioRem Inc. (2003–2025)
The table below shows the annual cash flow conversion efficiency of BioRem Inc. from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see market value of BioRem Inc..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$14.93 Million ≈ $10.80 Million |
CA$7.64 Million ≈ $5.53 Million |
0.512x | +47.56% |
| 2024-12-31 | CA$10.63 Million ≈ $7.69 Million |
CA$3.69 Million ≈ $2.67 Million |
0.347x | +375.61% |
| 2023-12-31 | CA$6.72 Million ≈ $4.86 Million |
CA$490.03K ≈ $354.48K |
0.073x | -77.19% |
| 2022-12-31 | CA$4.52 Million ≈ $3.27 Million |
CA$1.44 Million ≈ $1.05 Million |
0.320x | -83.40% |
| 2021-12-31 | CA$1.96 Million ≈ $1.42 Million |
CA$3.78 Million ≈ $2.74 Million |
1.925x | +680.67% |
| 2020-12-31 | CA$13.52 Million ≈ $9.78 Million |
CA$3.34 Million ≈ $2.41 Million |
0.247x | +14.39% |
| 2019-12-31 | CA$11.72 Million ≈ $8.48 Million |
CA$2.53 Million ≈ $1.83 Million |
0.216x | +110161.99% |
| 2018-12-31 | CA$12.90 Million ≈ $9.33 Million |
CA$-2.53K ≈ $-1.83K |
0.000x | -100.12% |
| 2017-12-31 | CA$7.30 Million ≈ $5.28 Million |
CA$1.17 Million ≈ $848.71K |
0.161x | +150.15% |
| 2016-12-31 | CA$2.43 Million ≈ $1.76 Million |
CA$-777.78K ≈ $-562.63K |
-0.320x | -128.83% |
| 2015-12-31 | CA$1.93 Million ≈ $1.40 Million |
CA$2.15 Million ≈ $1.55 Million |
1.112x | -35.61% |
| 2014-12-31 | CA$-258.09K ≈ $-186.70K |
CA$-445.59K ≈ $-322.34K |
1.727x | +108.19% |
| 2013-12-31 | CA$884.72K ≈ $639.99K |
CA$733.71K ≈ $530.75K |
0.829x | +108.54% |
| 2012-12-31 | CA$54.63K ≈ $39.52K |
CA$-530.21K ≈ $-383.54K |
-9.706x | -774.52% |
| 2011-12-31 | CA$629.11K ≈ $455.09K |
CA$905.26K ≈ $654.85K |
1.439x | +533.27% |
| 2010-12-31 | CA$5.59 Million ≈ $4.05 Million |
CA$-1.86 Million ≈ $-1.34 Million |
-0.332x | -233.70% |
| 2009-12-31 | CA$8.55 Million ≈ $6.18 Million |
CA$2.12 Million ≈ $1.54 Million |
0.248x | +182.15% |
| 2008-12-31 | CA$8.79 Million ≈ $6.36 Million |
CA$-2.66 Million ≈ $-1.92 Million |
-0.302x | -24.45% |
| 2007-12-31 | CA$8.52 Million ≈ $6.16 Million |
CA$-2.07 Million ≈ $-1.50 Million |
-0.243x | -339.10% |
| 2006-12-31 | CA$11.33 Million ≈ $8.20 Million |
CA$1.15 Million ≈ $832.95K |
0.102x | +163.83% |
| 2005-12-31 | CA$8.63 Million ≈ $6.25 Million |
CA$-1.37 Million ≈ $-994.47K |
-0.159x | -161.68% |
| 2004-12-31 | CA$384.55K ≈ $278.18K |
CA$-23.40K ≈ $-16.93K |
-0.061x | -120.61% |
| 2003-12-31 | CA$-968.76K ≈ $-700.79K |
CA$-285.98K ≈ $-206.87K |
0.295x | -- |
About BioRem Inc.
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It a… Read more